Exploring the contribution of the mitochondrial disulfide relay system to Parkinson’s disease: the PINK1/CHCHD4 interplay

Exploring the contribution of the mitochondrial disulfide relay system to Parkinson’s disease: the PINK1/CHCHD4 interplay

Bibliographic Details
Main Authors:	Giuseppe Arena, Nazanine Modjtahedi, Rejko Kruger
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=11;spage=2222;epage=2224;aulast=Arena

Similar Items

The Mia40/CHCHD4 Oxidative Folding System: Redox Regulation and Signaling in the Mitochondrial Intermembrane Space
by: Eleanor Dickson-Murray, et al.
Published: (2021-04-01)

Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion
by: Tian Liu, et al.
Published: (2023-12-01)

CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response
by: Yu Ruan, et al.
Published: (2022-02-01)

Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10–what distinguishes the two?
by: Aya Ikeda, et al.
Published: (2022-09-01)

Corrigendum: VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
by: Thomas Briston, et al.
Published: (2021-09-01)

Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations
by: Liu, Y-T, et al.
Published: (2020)

The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease
by: Dajana Grossmann, et al.
Published: (2020-09-01)

ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons
by: Sandra Harjuhaahto, et al.
Published: (2020-07-01)

Loss of Parkinson’s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c
by: Hongrui Meng, et al.
Published: (2017-06-01)

CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease
by: Lin Lu, et al.
Published: (2022-07-01)

Elevated CHCHD4 orchestrates mitochondrial oxidative phosphorylation to disturb hypoxic pulmonary hypertension
by: Yu Wang, et al.
Published: (2023-07-01)

Author Correction: TDP-43 and PINK1 mediate CHCHD10 S59L mutation–induced defects in Drosophila and in vitro
by: Minwoo Baek, et al.
Published: (2021-05-01)

CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder
by: Tianlin Jiang, et al.
Published: (2022-08-01)

Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson’s Disease
by: Maria Vizziello, et al.
Published: (2021-11-01)

Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease
by: Xiaodan Liu, et al.
Published: (2021-03-01)

PINK1 Protects against Staurosporine-Induced Apoptosis by Interacting with Beclin1 and Impairing Its Pro-Apoptotic Cleavage
by: Francesco Brunelli, et al.
Published: (2022-02-01)

CHCHD4 confers metabolic vulnerabilities to tumour cells through its control of the mitochondrial respiratory chain
by: Luke W. Thomas, et al.
Published: (2019-03-01)

CHCHD4 Regulates Intracellular Oxygenation and Perinuclear Distribution of Mitochondria
by: Luke W. Thomas, et al.
Published: (2017-04-01)

Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme
by: Pauline Mencke, et al.
Published: (2020-08-01)

Identification and Characterization of CHCHD1, AURKAIP1, and CRIF1 as New Members of the Mammalian Mitochondrial Ribosome
by: Emine C Koc, et al.
Published: (2013-07-01)

Impaired AIF-CHCHD4 interaction and mitochondrial calcium overload contribute to auditory neuropathy spectrum disorder in patient-iPSC-derived neurons with AIFM1 variant
by: Yue Qiu, et al.
Published: (2023-06-01)

Chchd10 is dispensable for myogenesis but critical for adipose browning
by: Wei Xia, et al.
Published: (2022-04-01)

Corrigendum: CHCHD4 Regulates Intracellular Oxygenation and Perinuclear Distribution of Mitochondria
by: Luke W. Thomas, et al.
Published: (2019-01-01)

A novel CHCHD10 mutation implicates a Mia40‐dependent mitochondrial import deficit in ALS
by: Carina Lehmer, et al.
Published: (2018-06-01)

OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy
by: Mario K. Shammas, et al.
Published: (2022-07-01)

Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
by: Emmanuelle C. Genin, et al.
Published: (2018-11-01)

Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson’s disease phenotypes in vivo and in cell models
by: Murni Tio, et al.
Published: (2024-02-01)

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
by: Preston Ge, et al.
Published: (2020-03-01)

Genetic landscape of Parkinson’s disease and related diseases in Luxembourg
by: Zied Landoulsi, et al.
Published: (2023-12-01)

CHCHD2: The Power House's Potential Prognostic Factor for Cancer?
by: Rohit Gundamaraju, et al.
Published: (2021-01-01)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
by: Matthew J. Farrer, et al.
Published: (2021-04-01)

Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort
by: Sylvia Binck, et al.
Published: (2020-11-01)

Mutant CHCHD10 causes an extensive metabolic rewiring that precedes OXPHOS dysfunction in a murine model of mitochondrial cardiomyopathy
by: Nicole M. Sayles, et al.
Published: (2022-03-01)

The roles of PINK1 and Parkin in Parkinson's disease.
by: Rachel Jones
Published: (2010-01-01)

Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
by: Suzana Gispert, et al.
Published: (2009-06-01)

PINK1 mutants associated with recessive Parkinson’s disease are defective in inhibiting mitochondrial release of cytochrome c
by: Hung-Li Wang, et al.
Published: (2007-11-01)

Corrigendum: Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort
by: Sylvia Binck, et al.
Published: (2021-01-01)

Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2
by: Satoru Torii, et al.
Published: (2023-09-01)

Multilingual Validation of the First French Version of Munich Dysphagia Test—Parkinson's Disease (MDT-PD) in the Luxembourg Parkinson's Study
by: Janine A. Simons, et al.
Published: (2019-11-01)

Mitochondrial-Dependent and Independent Functions of PINK1
by: Xiusheng Chen, et al.
Published: (2022-07-01)